|
G |
Abcb11 |
ATP-binding cassette, sub-family B member 11 |
multiple interactions decreases activity |
ISO |
Reserpine inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Reserpine results in decreased activity of ABCB11 protein |
CTD |
PMID:20829430 PMID:23956101 PMID:24014644 |
|
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
multiple interactions increases expression decreases activity |
ISO EXP |
Cycloheximide promotes the reaction [Reserpine results in increased expression of ABCB1 mRNA]; Reserpine inhibits the reaction [ABCB1 protein affects the export of calcein AM]; Reserpine inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Reserpine inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine] Reserpine results in increased expression of ABCB1 mRNA; Reserpine results in increased expression of ABCB1 protein Reserpine results in decreased activity of ABCB1 protein Reserpine inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon] |
CTD |
PMID:7476894 PMID:8632764 PMID:10617675 PMID:12235267 PMID:19528478 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
multiple interactions |
ISO |
Reserpine inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]; Reserpine inhibits the reaction [ABCG2 protein results in increased transport of irinotecan] |
CTD |
PMID:12869632 |
|
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions affects activity |
ISO |
[Plant Extracts results in increased abundance of Dronabinol] inhibits the reaction [Reserpine affects the activity of ACHE protein] |
CTD |
PMID:28212939 |
|
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
|
|
G |
Adra1d |
adrenergic receptor, alpha 1d |
increases response to substance increases expression |
ISO |
ADRA1D protein results in increased susceptibility to Reserpine Reserpine results in increased expression of ADRA1D mRNA |
CTD |
PMID:15159276 PMID:17676312 |
|
NCBI chr 2:131,387,277...131,404,417
Ensembl chr 2:131,387,770...131,404,203
|
|
G |
Adra2a |
adrenergic receptor, alpha 2a |
increases expression |
ISO |
Reserpine results in increased expression of ADRA2A mRNA |
CTD |
PMID:11264240 |
|
NCBI chr19:54,033,690...54,037,413
Ensembl chr19:54,032,582...54,037,413
|
|
G |
Adrb1 |
adrenergic receptor, beta 1 |
increases expression increases stability |
ISO |
Reserpine results in increased expression of ADRB1 mRNA; Reserpine results in increased expression of ADRB1 protein Reserpine results in increased stability of ADRB1 mRNA |
CTD |
PMID:1336118 |
|
NCBI chr19:56,710,549...56,713,582
Ensembl chr19:56,710,631...56,721,545
|
|
G |
Adrb2 |
adrenergic receptor, beta 2 |
increases expression |
ISO |
Reserpine results in increased expression of ADRB2 mRNA |
CTD |
PMID:1664493 |
|
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
increases expression |
ISO |
Reserpine results in increased expression of AGTR2 mRNA; Reserpine results in increased expression of AGTR2 protein |
CTD |
PMID:20964730 |
|
NCBI chr X:21,350,863...21,355,072
Ensembl chr X:21,350,783...21,355,403
|
|
G |
Akr1b10 |
aldo-keto reductase family 1, member B10 |
increases expression |
ISO |
Reserpine results in increased expression of AKR1B10 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
decreases phosphorylation multiple interactions |
EXP |
Reserpine results in decreased phosphorylation of AKT1 protein arsenic trioxide promotes the reaction [Reserpine results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:26114099 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Amd1 |
S-adenosylmethionine decarboxylase 1 |
multiple interactions |
EXP |
Reserpine inhibits the reaction [Folic Acid results in increased activity of AMD1 protein] |
CTD |
PMID:17371283 |
|
NCBI chr10:40,163,454...40,178,184
Ensembl chr10:40,163,454...40,178,184
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Reserpine inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein] |
CTD |
PMID:29162470 |
|
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
|
|
G |
Arc |
activity regulated cytoskeletal-associated protein |
multiple interactions |
ISO |
Reserpine inhibits the reaction [Cocaine results in increased expression of ARC mRNA] |
CTD |
PMID:7722525 |
|
NCBI chr15:74,540,930...74,544,419
Ensembl chr15:74,540,932...74,544,419
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions increases expression |
ISO |
IAPP protein inhibits the reaction [Reserpine results in increased expression of BAX protein] |
CTD |
PMID:19463876 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions decreases expression |
ISO |
IAPP protein inhibits the reaction [Reserpine results in decreased expression of BCL2 protein] |
CTD |
PMID:19463876 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bdnf |
brain derived neurotrophic factor |
decreases expression multiple interactions |
EXP ISO |
Reserpine results in decreased expression of BDNF protein arsenic trioxide promotes the reaction [Reserpine results in decreased expression of BDNF protein] cerebrolysin inhibits the reaction [Reserpine results in decreased expression of BDNF protein]; Fluoxetine inhibits the reaction [Reserpine results in decreased expression of BDNF protein] |
CTD |
PMID:26114099 PMID:33279466 |
|
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
affects binding |
ISO |
Reserpine binds to BIRC5 promoter |
CTD |
PMID:17968851 |
|
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
|
|
G |
C3 |
complement component 3 |
affects expression |
ISO |
Reserpine affects the expression of C3 mRNA |
CTD |
PMID:18363858 |
|
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP3 protein] |
CTD |
PMID:19463876 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases activity |
ISO |
IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP8 protein] |
CTD |
PMID:19463876 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Cat |
catalase |
multiple interactions increases expression decreases expression |
ISO |
Plant Extracts inhibits the reaction [Reserpine results in decreased expression of CAT protein]; Quercetin inhibits the reaction [Reserpine results in decreased expression of CAT protein] Reserpine results in increased expression of CAT protein |
CTD |
PMID:14685008 PMID:16444668 PMID:19109989 PMID:19761039 PMID:20628966 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Reserpine results in decreased expression of CCND1 mRNA; Reserpine results in decreased expression of CCND1 protein |
CTD |
PMID:19607803 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein |
CTD |
PMID:11318962 |
|
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
|
|
G |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
multiple interactions |
ISO |
[Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate affects the localization of CDKN2A protein]; [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of CDKN2A mRNA] |
CTD |
PMID:18504326 |
|
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
|
|
G |
Chga |
chromogranin A |
multiple interactions increases activity increases expression |
EXP ISO |
CHGA protein alternative form inhibits the reaction [Reserpine results in increased activity of CHGA promoter]; Chlorisondamine inhibits the reaction [Reserpine results in increased activity of CHGA promoter] Reserpine results in increased expression of CHGA mRNA |
CTD |
PMID:1907749 PMID:8189248 PMID:12799369 |
|
NCBI chr12:102,521,200...102,531,286
Ensembl chr12:102,521,228...102,531,287
|
|
G |
Chgb |
chromogranin B |
increases expression |
ISO |
Reserpine results in increased expression of CHGB mRNA; Reserpine results in increased expression of CHGB protein |
CTD |
PMID:1907749 PMID:8189248 PMID:8361347 |
|
NCBI chr 2:132,623,562...132,636,999
Ensembl chr 2:132,623,198...132,636,999
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1, CNS |
increases expression decreases expression |
ISO |
Reserpine results in increased expression of CHRM1 mRNA Reserpine results in decreased expression of CHRM1 protein |
CTD |
PMID:1506860 |
|
NCBI chr19:8,641,369...8,660,970
Ensembl chr19:8,641,153...8,660,951
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
decreases expression |
ISO |
Reserpine results in decreased expression of CNR1 mRNA |
CTD |
PMID:11358453 |
|
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
|
|
G |
Cpe |
carboxypeptidase E |
increases expression |
ISO |
Reserpine results in increased expression of CPE mRNA |
CTD |
PMID:8189248 |
|
NCBI chr 8:65,045,576...65,146,143
Ensembl chr 8:65,045,576...65,146,088
|
|
G |
Crem |
cAMP responsive element modulator |
multiple interactions increases expression |
ISO |
Reserpine promotes the reaction [CREM protein binds to TH promoter] Reserpine results in increased expression of CREM mRNA alternative form; Reserpine results in increased expression of CREM protein; Reserpine results in increased expression of CREM protein alternative form |
CTD |
PMID:8810303 PMID:11438978 |
|
NCBI chr18:3,263,181...3,337,688
Ensembl chr18:3,266,048...3,337,748
|
|
G |
Crh |
corticotropin releasing hormone |
increases expression |
ISO |
Reserpine results in increased expression of CRH mRNA; Reserpine results in increased expression of CRH protein |
CTD |
PMID:1850078 |
|
NCBI chr 3:19,747,565...19,749,560
Ensembl chr 3:19,747,565...19,749,560
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Reserpine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A1 protein]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:15627480 PMID:18493746 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]; [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] |
CTD |
PMID:16510159 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
multiple interactions |
ISO |
[Reserpine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA |
CTD |
PMID:17041008 |
|
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
|
|
G |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
increases expression |
ISO |
Reserpine results in increased expression of CYP3A5 protein |
CTD |
PMID:8632764 |
|
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
|
|
G |
Dbh |
dopamine beta hydroxylase |
decreases activity increases activity increases stability increases expression |
ISO |
Reserpine results in decreased activity of DBH protein Reserpine results in increased activity of DBH protein Reserpine results in increased stability of DBH protein Reserpine results in increased expression of DBH mRNA |
CTD |
PMID:1359376 PMID:2325165 PMID:7984052 PMID:8189248 |
|
NCBI chr 2:27,055,519...27,073,216
Ensembl chr 2:27,055,245...27,073,212
|
|
G |
Ddc |
dopa decarboxylase |
increases expression |
ISO |
Reserpine results in increased expression of DDC mRNA |
CTD |
PMID:1359376 |
|
NCBI chr11:11,764,101...11,848,144
Ensembl chr11:11,764,101...11,848,144
|
|
G |
Drd1 |
dopamine receptor D1 |
increases expression |
ISO |
Reserpine results in increased expression of DRD1 mRNA |
CTD |
PMID:8419537 |
|
NCBI chr13:54,205,202...54,209,677
Ensembl chr13:54,205,202...54,209,724
|
|
G |
Drd2 |
dopamine receptor D2 |
multiple interactions increases expression |
EXP ISO |
DRD2 protein affects the susceptibility to [8-(3-chlorostyryl)caffeine co-treated with Reserpine] Reserpine results in increased expression of DRD2 mRNA; Reserpine results in increased expression of DRD2 mRNA alternative form |
CTD |
PMID:1331675 PMID:8419537 PMID:11172060 |
|
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions increases expression |
ISO |
[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA; eticlopride inhibits the reaction [[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA]; Quinpirole inhibits the reaction [Reserpine results in increased expression of EGR1 mRNA]; Reserpine promotes the reaction [Dextroamphetamine results in increased expression of EGR1 mRNA]; SCH 23390 inhibits the reaction [[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA]; SCH 23390 inhibits the reaction [Reserpine promotes the reaction [Dextroamphetamine results in increased expression of EGR1 mRNA]] Reserpine results in increased expression of EGR1 mRNA; Reserpine results in increased expression of EGR1 protein |
CTD |
PMID:1347779 PMID:8063705 PMID:9729266 PMID:9890435 |
|
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
increases response to substance |
ISO |
ERBB2 protein results in increased susceptibility to Reserpine |
CTD |
PMID:8093862 |
|
NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
|
|
G |
Fabp7 |
fatty acid binding protein 7, brain |
affects expression |
ISO |
Reserpine affects the expression of FABP7 mRNA |
CTD |
PMID:18363858 |
|
NCBI chr10:57,661,019...57,664,546
Ensembl chr10:57,660,977...57,664,546
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions increases phosphorylation increases expression |
ISO |
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine promotes the reaction [Reserpine results in increased expression of FOS protein]; 3,7-dimethyl-1-propargylxanthine inhibits the reaction [Reserpine results in increased expression of FOS protein]; 8-(3-chlorostyryl)caffeine promotes the reaction [Quinpirole inhibits the reaction [Reserpine results in increased expression of FOS protein]]; Quinpirole inhibits the reaction [Reserpine results in increased expression of FOS protein]; Quinpirole promotes the reaction [Reserpine results in increased expression of FOS protein]; Reserpine inhibits the reaction [[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Quinpirole] results in increased expression of FOS protein]; Reserpine inhibits the reaction [Cocaine results in increased expression of FOS protein]; Reserpine promotes the reaction [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased expression of FOS protein]; Reserpine promotes the reaction [Amphetamine results in increased expression of FOS protein]; Reserpine promotes the reaction [Quinpirole results in increased expression of FOS protein]; Theophylline inhibits the reaction [Reserpine results in increased expression of FOS protein] Reserpine results in increased phosphorylation of FOS protein Reserpine results in increased expression of FOS mRNA; Reserpine results in increased expression of FOS protein |
CTD |
PMID:1359376 PMID:1686849 PMID:2118661 PMID:7845612 PMID:7914358 PMID:8100600 PMID:8102797 PMID:8577368 PMID:8864302 PMID:9210518 More...
|
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
increases expression multiple interactions |
ISO |
Reserpine results in increased expression of GAD1 mRNA Clenbuterol inhibits the reaction [Reserpine results in increased expression of GAD1 mRNA] |
CTD |
PMID:8774452 |
|
NCBI chr 2:70,392,109...70,432,358
Ensembl chr 2:70,383,416...70,432,358
|
|
G |
Gal |
galanin and GMAP prepropeptide |
decreases expression multiple interactions increases expression |
ISO |
Reserpine results in decreased expression of GAL mRNA Desipramine inhibits the reaction [Reserpine results in increased expression of GAL mRNA] |
CTD |
PMID:1279347 PMID:1698642 PMID:1705056 PMID:1717808 PMID:9512271 PMID:19598284 More...
|
|
NCBI chr19:3,459,915...3,464,544
Ensembl chr19:3,459,915...3,464,544
|
|
G |
Gast |
gastrin |
multiple interactions |
ISO |
Reserpine inhibits the reaction [Levodopa results in decreased cleavage of GAST protein] |
CTD |
PMID:10332097 |
|
NCBI chr11:100,225,233...100,227,823
Ensembl chr11:100,225,233...100,227,822
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
increases expression |
ISO |
Reserpine results in increased expression of GCH1 mRNA; Reserpine results in increased expression of GCH1 mRNA alternative form |
CTD |
PMID:8103077 |
|
NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
ISO |
Reserpine results in increased expression of GCNT3 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr 9:69,938,777...69,947,172
Ensembl chr 9:69,938,778...69,945,370
|
|
G |
Gnai1 |
G protein subunit alpha i1 |
increases expression |
ISO |
Reserpine results in increased expression of GNAI1 protein |
CTD |
PMID:11264240 |
|
NCBI chr 5:18,470,133...18,565,411
Ensembl chr 5:18,470,133...18,565,353
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
increases expression |
ISO |
Reserpine results in increased expression of GNAI2 mRNA; Reserpine results in increased expression of GNAI2 protein |
CTD |
PMID:8419537 PMID:11264240 |
|
NCBI chr 9:107,491,324...107,512,542
Ensembl chr 9:107,491,324...107,512,566
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
increases expression |
ISO |
Reserpine results in increased expression of GNAI3 protein |
CTD |
PMID:11264240 |
|
NCBI chr 3:108,014,591...108,053,468
Ensembl chr 3:108,014,596...108,053,462
|
|
G |
Gnao1 |
guanine nucleotide binding protein, alpha O |
increases expression |
ISO |
Reserpine results in increased expression of GNAO1 mRNA; Reserpine results in increased expression of GNAO1 protein |
CTD |
PMID:8419537 PMID:11264240 |
|
NCBI chr 8:94,537,213...94,696,016
Ensembl chr 8:94,536,594...94,696,016
|
|
G |
Gnas |
GNAS complex locus |
increases expression decreases expression |
ISO |
Reserpine results in increased expression of GNAS mRNA; Reserpine results in increased expression of GNAS protein Reserpine results in decreased expression of GNAS protein alternative form |
CTD |
PMID:1336118 PMID:8419537 PMID:11264240 |
|
NCBI chr 2:174,126,113...174,188,537
Ensembl chr 2:174,126,113...174,188,537
|
|
G |
Grm5 |
glutamate receptor, metabotropic 5 |
decreases expression increases expression |
ISO |
Reserpine results in decreased expression of GRM5 mRNA Reserpine results in increased expression of GRM5 protein |
CTD |
PMID:16890937 |
|
NCBI chr 7:87,233,212...87,784,271
Ensembl chr 7:87,233,376...87,784,115
|
|
G |
Hgf |
hepatocyte growth factor |
increases expression |
ISO |
Reserpine results in increased expression of HGF protein |
CTD |
PMID:16081063 |
|
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
|
|
G |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
multiple interactions |
EXP |
HSPG2 gene results in increased susceptibility to [Haloperidol co-treated with Reserpine] |
CTD |
PMID:20072119 |
|
NCBI chr 4:137,196,062...137,297,941
Ensembl chr 4:137,196,080...137,297,941
|
|
G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
decreases expression |
EXP |
Reserpine results in decreased expression of HTR1A protein |
CTD |
PMID:26114099 |
|
NCBI chr13:105,580,040...105,584,630
Ensembl chr13:105,580,147...105,584,630
|
|
G |
Iapp |
islet amyloid polypeptide |
multiple interactions |
ISO |
IAPP protein inhibits the reaction [Reserpine results in decreased expression of BCL2 protein]; IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP3 protein]; IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP8 protein]; IAPP protein inhibits the reaction [Reserpine results in increased expression of BAX protein]; IAPP protein inhibits the reaction [Reserpine results in increased expression of TNFSF10 protein] |
CTD |
PMID:19463876 |
|
NCBI chr 6:142,244,151...142,249,546
Ensembl chr 6:142,244,149...142,249,687
|
|
G |
Il10 |
interleukin 10 |
decreases expression multiple interactions |
ISO |
Reserpine results in decreased expression of IL10 mRNA; Reserpine results in decreased expression of IL10 protein SCH 23390 inhibits the reaction [Reserpine results in decreased expression of IL10 mRNA]; SCH 23390 inhibits the reaction [Reserpine results in decreased expression of IL10 protein] |
CTD |
PMID:16985181 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
Reserpine results in increased expression of IL18 mRNA |
CTD |
PMID:8999896 |
|
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Jun |
jun proto-oncogene |
increases expression |
ISO |
Reserpine results in increased expression of JUN mRNA |
CTD |
PMID:1359376 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Junb |
jun B proto-oncogene |
multiple interactions |
ISO |
Reserpine promotes the reaction [Dextroamphetamine results in increased expression of JUNB mRNA]; SCH 23390 inhibits the reaction [Reserpine promotes the reaction [Dextroamphetamine results in increased expression of JUNB mRNA]] |
CTD |
PMID:1347779 |
|
NCBI chr 8:85,703,538...85,705,377
Ensembl chr 8:85,701,113...85,705,347
|
|
G |
Kcna3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
decreases activity multiple interactions |
ISO |
Reserpine results in decreased activity of KCNA3 protein [Reserpine results in decreased activity of KCNA3 protein] which results in decreased import of Thallium |
CTD |
PMID:21362439 |
|
NCBI chr 3:106,943,486...106,947,223
Ensembl chr 3:106,943,485...106,945,386
|
|
G |
Kcna5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
increases expression |
ISO |
Reserpine results in increased expression of KCNA5 mRNA |
CTD |
PMID:12606256 |
|
NCBI chr 6:126,509,514...126,512,518
Ensembl chr 6:126,509,514...126,512,375
|
|
G |
Kcnd2 |
potassium voltage-gated channel, Shal-related family, member 2 |
decreases expression |
ISO |
Reserpine results in decreased expression of KCND2 mRNA |
CTD |
PMID:12606256 |
|
NCBI chr 6:21,212,101...21,729,804
Ensembl chr 6:21,215,502...21,729,804
|
|
G |
Kcnd3 |
potassium voltage-gated channel, Shal-related family, member 3 |
decreases expression |
ISO |
Reserpine results in decreased expression of KCND3 mRNA |
CTD |
PMID:12606256 |
|
NCBI chr 3:105,359,206...105,581,318
Ensembl chr 3:105,359,646...105,581,318
|
|
G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
decreases activity multiple interactions |
ISO |
Reserpine results in decreased activity of KCNH2 protein [Reserpine results in decreased activity of KCNH2 protein] which results in decreased import of Thallium |
CTD |
PMID:21362439 PMID:28551711 |
|
NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
|
|
G |
Lep |
leptin |
increases expression |
EXP |
Reserpine results in increased expression of LEP mRNA |
CTD |
PMID:10050748 |
|
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
|
|
G |
Myc |
myelocytomatosis oncogene |
increases response to substance decreases expression |
EXP ISO |
MYC protein results in increased susceptibility to Reserpine Reserpine results in decreased expression of MYC protein |
CTD |
PMID:8093862 PMID:19607803 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
increases expression |
ISO |
Reserpine results in increased expression of NCF1 mRNA; Reserpine results in increased expression of NCF1 protein |
CTD |
PMID:20964730 |
|
NCBI chr 5:134,248,907...134,258,479
Ensembl chr 5:134,248,907...134,258,479
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
decreases activity |
EXP |
Reserpine results in decreased activity of NFE2L2 protein |
CTD |
PMID:30203046 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Ngf |
nerve growth factor |
increases expression |
ISO |
Reserpine results in increased expression of NGF mRNA; Reserpine results in increased expression of NGF protein |
CTD |
PMID:1996081 PMID:8593794 |
|
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
|
|
G |
Nos1 |
nitric oxide synthase 1, neuronal |
increases expression |
ISO |
Reserpine results in increased expression of NOS1 mRNA; Reserpine results in increased expression of NOS1 protein |
CTD |
PMID:7533141 |
|
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
|
|
G |
Npy |
neuropeptide Y |
multiple interactions decreases expression increases expression |
ISO |
Chlorisondamine inhibits the reaction [Reserpine results in increased expression of NPY mRNA]; Chlorisondamine promotes the reaction [Reserpine results in increased expression of NPY mRNA]; Dexamethasone inhibits the reaction [Reserpine results in increased expression of NPY mRNA] Reserpine results in decreased expression of NPY mRNA; Reserpine results in decreased expression of NPY protein Reserpine results in increased expression of NPY mRNA; Reserpine results in increased expression of NPY protein |
CTD |
PMID:1671012 PMID:1676830 PMID:1687976 PMID:1698642 PMID:1713314 PMID:1714554 PMID:1878751 PMID:1907749 PMID:2233698 PMID:2897091 PMID:2903502 PMID:3215285 PMID:3805164 PMID:7644023 PMID:7911764 PMID:8189248 PMID:20504635 More...
|
|
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
[Reserpine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA |
CTD |
PMID:17041008 |
|
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions decreases activity |
ISO EXP |
[Reserpine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA Reserpine results in decreased activity of NR1I3 protein |
CTD |
PMID:17041008 PMID:30203046 |
|
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
increases expression |
ISO |
Reserpine results in increased expression of NR3C1 mRNA |
CTD |
PMID:7984052 |
|
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
|
|
G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
multiple interactions decreases expression |
EXP |
arsenic trioxide promotes the reaction [Reserpine results in decreased expression of NTRK2 protein] |
CTD |
PMID:26114099 |
|
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
|
|
G |
Nts |
neurotensin |
increases expression |
ISO |
Reserpine results in increased expression of NTS mRNA |
CTD |
PMID:1850078 |
|
NCBI chr10:102,317,617...102,326,294
Ensembl chr10:102,317,617...102,326,347
|
|
G |
Odc1 |
ornithine decarboxylase, structural 1 |
decreases expression multiple interactions |
ISO EXP |
Reserpine results in decreased expression of ODC1 protein Reserpine inhibits the reaction [CB 3717 results in increased activity of ODC1 protein]; Reserpine inhibits the reaction [CB 3717 results in increased expression of ODC1 mRNA]; Reserpine inhibits the reaction [Testosterone results in increased activity of ODC1 protein]; Reserpine inhibits the reaction [Testosterone results in increased expression of ODC1 mRNA] |
CTD |
PMID:6519379 PMID:9194572 PMID:10354516 PMID:17371283 |
|
NCBI chr12:17,594,906...17,601,503
Ensembl chr12:17,594,795...17,601,506
|
|
G |
Pam |
peptidylglycine alpha-amidating monooxygenase |
increases expression |
ISO |
Reserpine results in increased expression of PAM mRNA |
CTD |
PMID:8189248 |
|
NCBI chr 1:97,748,816...98,023,578
Ensembl chr 1:97,722,839...98,023,371
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of PCNA protein |
CTD |
PMID:11318962 |
|
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
|
|
G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
increases expression |
ISO |
Reserpine results in increased expression of PCSK2 mRNA |
CTD |
PMID:8189248 |
|
NCBI chr 2:143,388,053...143,658,204
Ensembl chr 2:143,388,076...143,658,205
|
|
G |
Penk |
preproenkephalin |
multiple interactions decreases expression increases expression |
ISO |
Apomorphine inhibits the reaction [Reserpine results in increased expression of PENK mRNA] Reserpine results in decreased expression of PENK mRNA Reserpine results in increased expression of PENK mRNA; Reserpine results in increased expression of PENK protein |
CTD |
PMID:1331675 PMID:1850078 PMID:3188958 PMID:3838946 PMID:4078631 PMID:7494455 PMID:17719177 More...
|
|
NCBI chr 4:4,133,536...4,138,815
Ensembl chr 4:4,133,531...4,138,819
|
|
G |
Pnmt |
phenylethanolamine-N-methyltransferase |
multiple interactions decreases expression increases expression |
ISO |
Chlorisondamine inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA]; Dexamethasone inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA]; POMC protein alternative form inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA]; Reserpine results in increased expression of and results in increased activity of PNMT protein Reserpine results in increased expression of PNMT mRNA |
CTD |
PMID:1359376 PMID:1687976 PMID:1714554 PMID:2903502 PMID:8063705 PMID:8479280 PMID:20504635 More...
|
|
NCBI chr11:98,277,449...98,279,006
Ensembl chr11:98,277,276...98,279,007
|
|
G |
Pomc |
pro-opiomelanocortin-alpha |
increases expression multiple interactions |
ISO |
Reserpine results in increased expression of POMC mRNA; Reserpine results in increased expression of POMC protein alternative form POMC protein alternative form inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA] |
CTD |
PMID:8479280 PMID:20504635 |
|
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
|
|
G |
Prkaca |
protein kinase, cAMP dependent, catalytic, alpha |
decreases expression |
EXP |
Reserpine results in decreased expression of PRKACA protein |
CTD |
PMID:26114099 |
|
NCBI chr 8:84,699,607...84,723,073
Ensembl chr 8:84,699,622...84,723,072
|
|
G |
Prl |
prolactin |
increases expression |
ISO |
Reserpine results in increased expression of PRL protein |
CTD |
PMID:11071396 |
|
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
Reserpine results in increased expression of PTGS2 protein |
CTD |
PMID:16081063 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Pts |
6-pyruvoyl-tetrahydropterin synthase |
increases expression |
ISO |
Reserpine results in increased expression of PTS mRNA |
CTD |
PMID:7545485 |
|
NCBI chr 9:50,432,917...50,440,017
Ensembl chr 9:50,432,917...50,440,024
|
|
G |
Rasd2 |
RASD family, member 2 |
decreases expression |
ISO |
Reserpine results in decreased expression of RASD2 mRNA |
CTD |
PMID:16352400 |
|
NCBI chr 8:75,940,572...75,950,741
Ensembl chr 8:75,940,572...75,950,741
|
|
G |
Rgs10 |
regulator of G-protein signalling 10 |
decreases expression |
ISO |
Reserpine results in decreased expression of RGS10 mRNA |
CTD |
PMID:14505795 |
|
NCBI chr 7:127,975,345...128,020,993
Ensembl chr 7:127,975,345...128,020,482
|
|
G |
Rgs2 |
regulator of G-protein signaling 2 |
decreases expression |
ISO |
Reserpine results in decreased expression of RGS2 mRNA |
CTD |
PMID:14505795 |
|
NCBI chr 1:143,875,076...143,879,887
Ensembl chr 1:143,875,076...143,879,899
|
|
G |
Rgs4 |
regulator of G-protein signaling 4 |
decreases expression |
ISO |
Reserpine results in decreased expression of RGS4 mRNA |
CTD |
PMID:14505795 |
|
NCBI chr 1:169,569,046...169,575,211
Ensembl chr 1:169,569,046...169,575,211
|
|
G |
Rgs5 |
regulator of G-protein signaling 5 |
decreases expression |
ISO |
Reserpine results in decreased expression of RGS5 mRNA |
CTD |
PMID:14505795 |
|
NCBI chr 1:169,483,070...169,523,367
Ensembl chr 1:169,483,070...169,523,382
|
|
G |
Rgs8 |
regulator of G-protein signaling 8 |
decreases expression |
ISO |
Reserpine results in decreased expression of RGS8 mRNA |
CTD |
PMID:14505795 |
|
NCBI chr 1:153,528,612...153,573,415
Ensembl chr 1:153,528,771...153,576,069
|
|
G |
Rgs9 |
regulator of G-protein signaling 9 |
affects response to substance decreases expression |
EXP ISO |
RGS9 affects the susceptibility to Reserpine Reserpine results in decreased expression of RGS9 mRNA |
CTD |
PMID:14505795 PMID:15728856 |
|
NCBI chr11:109,116,174...109,189,013
Ensembl chr11:109,116,181...109,188,955
|
|
G |
Scg2 |
secretogranin II |
increases expression |
ISO |
Reserpine results in increased expression of SCG2 mRNA |
CTD |
PMID:1907749 PMID:8189248 PMID:8361347 |
|
NCBI chr 1:79,412,083...79,417,743
Ensembl chr 1:79,412,386...79,417,837
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
multiple interactions |
ISO |
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 mRNA; [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 protein |
CTD |
PMID:11318962 |
|
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Siah1a |
siah E3 ubiquitin protein ligase 1A |
increases expression |
ISO |
Reserpine results in increased expression of SIAH1 mRNA |
CTD |
PMID:19607803 |
|
NCBI chr 8:87,442,450...87,472,634
Ensembl chr 8:87,450,635...87,472,562
|
|
G |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
decreases activity multiple interactions |
EXP ISO |
Reserpine results in decreased activity of SLC18A1 protein Reserpine inhibits the reaction [SLC18A1 protein results in increased uptake of Serotonin] |
CTD |
PMID:8245983 PMID:21712771 |
|
NCBI chr 8:69,490,360...69,547,951
Ensembl chr 8:69,490,363...69,541,887
|
|
G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
affects binding decreases response to substance decreases activity multiple interactions affects response to substance increases expression |
ISO EXP |
Reserpine binds to SLC18A2 protein SLC18A2 gene SNP results in decreased susceptibility to Reserpine Reserpine results in decreased activity of SLC18A2 protein Reserpine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin]; Serotonin inhibits the reaction [SLC18A2 protein binds to Reserpine] SLC18A2 affects the susceptibility to Reserpine Reserpine results in increased expression of SLC18A2 mRNA Reserpine inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] |
CTD |
PMID:1438304 PMID:7912402 PMID:8189248 PMID:9038139 PMID:15475732 PMID:17664021 PMID:18287335 PMID:29908239 PMID:33378168 More...
|
|
NCBI chr19:59,249,310...59,284,444
Ensembl chr19:59,249,328...59,284,444
|
|
G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
decreases expression |
ISO |
Reserpine results in decreased expression of SLC6A2 mRNA |
CTD |
PMID:7478180 PMID:7616203 |
|
NCBI chr 8:93,687,100...93,728,295
Ensembl chr 8:93,686,707...93,728,295
|
|
G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
decreases activity affects response to substance |
EXP |
Reserpine results in decreased activity of SLC6A3 protein SLC6A3 gene mutant form affects the susceptibility to Reserpine |
CTD |
PMID:17664021 PMID:19615345 |
|
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
|
|
G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
decreases expression |
ISO |
Reserpine results in decreased expression of SLC6A4 mRNA |
CTD |
PMID:10027743 |
|
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
|
|
G |
Snca |
synuclein, alpha |
affects response to substance multiple interactions increases expression |
EXP ISO |
SNCA protein mutant form affects the susceptibility to Reserpine [Levodopa co-treated with Carbidopa] inhibits the reaction [Reserpine results in increased expression of SNCA protein]; Dextromethorphan promotes the reaction [zolmitriptan inhibits the reaction [Reserpine results in increased expression of SNCA protein]]; Glutamic Acid inhibits the reaction [zolmitriptan inhibits the reaction [Reserpine results in increased expression of SNCA protein]]; zolmitriptan inhibits the reaction [Reserpine results in increased expression of SNCA protein] |
CTD |
PMID:18622040 PMID:38229316 |
|
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
Reserpine results in increased expression of SQSTM1 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
|
|
G |
Syt7 |
synaptotagmin VII |
multiple interactions |
ISO |
[Reserpine co-treated with Apomorphine] results in increased expression of SYT7 mRNA |
CTD |
PMID:17719177 |
|
NCBI chr19:10,366,142...10,430,545
Ensembl chr19:10,366,454...10,430,544
|
|
G |
Tac1 |
tachykinin 1 |
multiple interactions increases expression |
ISO |
[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Reserpine co-treated with Quinpirole] results in increased expression of TAC1 mRNA; [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Reserpine] results in increased expression of TAC1 mRNA; Apomorphine promotes the reaction [Reserpine results in increased expression of TAC1 mRNA] |
CTD |
PMID:9751140 PMID:17719177 |
|
NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
|
|
G |
Tff1 |
trefoil factor 1 |
increases expression |
ISO |
Reserpine results in increased expression of TFF1 mRNA |
CTD |
PMID:35307500 |
|
NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251
|
|
G |
Th |
tyrosine hydroxylase |
increases expression multiple interactions increases stability affects activity decreases expression increases activity |
EXP ISO |
Reserpine results in increased expression of TH mRNA Bicuculline promotes the reaction [Reserpine affects the activity of TH protein]; Bicuculline promotes the reaction [Reserpine results in increased expression of TH mRNA]; Chlorisondamine inhibits the reaction [Reserpine results in increased expression of TH mRNA]; Chlorisondamine promotes the reaction [Reserpine results in increased expression of TH mRNA]; Desipramine inhibits the reaction [Reserpine results in increased expression of TH mRNA]; Reserpine promotes the reaction [CREM protein binds to TH promoter]; Reserpine results in increased expression of and results in increased activity of TH protein Reserpine results in increased stability of TH mRNA Reserpine results in decreased expression of TH mRNA Reserpine results in increased expression of TH mRNA; Reserpine results in increased expression of TH protein Reserpine results in increased activity of TH protein |
CTD |
PMID:1350653 PMID:1359376 PMID:1676830 PMID:1687822 PMID:1687976 PMID:1698642 PMID:1705056 PMID:1714554 PMID:1717808 PMID:1970845 PMID:1976760 PMID:1978789 PMID:1981253 PMID:2568627 PMID:2862954 PMID:2863328 PMID:2872048 PMID:2881815 PMID:2882513 PMID:2883324 PMID:2903502 PMID:7478180 PMID:7532593 PMID:7545485 PMID:7616203 PMID:7911764 PMID:8369965 PMID:8666980 PMID:9210518 PMID:9691425 PMID:11161478 PMID:11438978 PMID:20504635 More...
|
|
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
ISO |
Reserpine results in increased expression of TNF protein cerebrolysin inhibits the reaction [Reserpine results in increased expression of TNF protein]; Fluoxetine inhibits the reaction [Reserpine results in increased expression of TNF protein] |
CTD |
PMID:33279466 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
multiple interactions increases expression |
ISO |
IAPP protein inhibits the reaction [Reserpine results in increased expression of TNFSF10 protein] |
CTD |
PMID:19463876 |
|
NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
|
|
G |
Tph1 |
tryptophan hydroxylase 1 |
increases activity decreases activity |
ISO |
Reserpine results in increased activity of TPH1 protein Reserpine results in decreased activity of TPH1 protein |
CTD |
PMID:8369965 |
|
NCBI chr 7:46,294,065...46,321,961
Ensembl chr 7:46,294,065...46,321,961
|
|
G |
Try10 |
trypsin 10 |
decreases expression increases expression |
ISO |
Reserpine results in decreased expression of PRSS1 protein Reserpine results in increased expression of PRSS1 protein |
CTD |
PMID:8625754 |
|
NCBI chr 6:41,331,039...41,334,878
Ensembl chr 6:41,331,039...41,334,848
|
|
G |
Vgf |
VGF nerve growth factor inducible |
increases expression |
ISO |
Reserpine results in increased expression of VGF mRNA |
CTD |
PMID:8189248 |
|
NCBI chr 5:137,054,156...137,062,205
Ensembl chr 5:137,055,246...137,062,205
|
|
G |
Vip |
vasoactive intestinal polypeptide |
increases expression |
ISO |
Reserpine results in increased expression of VIP mRNA |
CTD |
PMID:1850078 |
|
NCBI chr10:5,589,131...5,597,617
Ensembl chr10:5,589,218...5,597,617
|
|